The Thailand cannabis licensing rules 2026 did not arrive as one simple “new cannabis law.” Two ministerial regulations took effect in April, while the medical-sales controls introduced in June 2025 continued to govern how flower reaches patients. For dispensary owners, the result is a layered system: one set of rules concerns cannabis flower, another concerns higher-THC extracts, and separate duties cover prescriptions, reporting and day-to-day retail conduct.
That distinction is essential. The PT33 prescription requirement did not begin with the April 2026 flower regulation, and the 31 December 2026 legacy extract deadline is not a universal expiry date for every flower shop.
The Regulatory Map in Four Lines
Before examining the details, owners should separate the framework into four parts:
- Cannabis flower: remains a controlled herb, with stricter licensing criteria added in April 2026.
- Extracts above 0.2% THC by weight: remain Category 5 narcotics under a separate licensing regime.
- Patient supply: cannabis flower may be supplied for medical use under a valid Thai PT33.
- Shop operations: licensing, PT28 reporting, traceability, document retention and inspection readiness must work together.
The Thailand cannabis licensing rules 2026 make more sense when these layers remain separate. A controlled-herb sales licence does not authorise every extract, and a prescription does not cure defects in the shop’s premises, stock or licence.
What Happened on 26 April 2026?
The first April change concerned cannabis and hemp extracts. The new regulation became effective on 26 April and applies to extracts regulated as Category 5 narcotics, including those containing more than 0.2% THC by weight.
A detailed summary of both April regulations explains that the extract framework restricts permitted purposes and applicant eligibility. It also reports that licences issued under the earlier 2020 and 2021 extract rules remain valid only until 31 December 2026.
This is not every flower retailer’s deadline. A business handling flower and regulated extracts may need separate permissions and transition plans. Product classification must come first.
What Happened on 30 April 2026?
Ministerial Regulation No. 2 B.E. 2569 was published on 30 April 2026. It amended the existing controlled-herb licensing framework by adding cannabis-flower-specific requirements for commercial sale, processing and export. DTAM’s official 2026 guidance for medical cannabis establishments explains how businesses must adapt to the amended framework.
The Thailand cannabis licensing rules 2026 did not invalidate every existing flower licence overnight. DTAM states that licences issued under the earlier framework may remain valid until their existing expiry dates, provided that their holders continue complying with the applicable conditions. A business wishing to continue after expiry must apply under the current requirements. Owners should examine the terms and expiry date of their own licences rather than rely on a general deadline in a headline.
A 2026 licensing analysis from Lex Bangkok provides additional English-language commentary on premises, supporting credentials, personnel and records. The Thai regulation and official guidance remain authoritative, so English explanations should not replace current Thai legal advice.
Change One: Standalone Retail Is No Longer the Model
The largest structural change is the narrowing of eligible establishments. The market is being pushed away from freestanding recreational-style retail and towards medically or professionally anchored premises.
For the medical supply of cannabis flower described in DTAM’s establishment guidance, the four principal models are a licensed healthcare facility, a licensed modern pharmacy, a licensed herbal-product establishment or the registered workplace of an officially certified folk healer. Certain eligible cultivation sites and other credentialed operators may have separate permissions for their authorised activities, but those permissions should not be confused with the four patient-service establishment models.
For dispensaries, the practical point is that a controlled-herb licence must sit on top of a qualifying establishment. Simply adding “medical” to the shop name, hiring someone in a white coat or installing a video-call booth does not transform an ineligible store.
Owners reviewing the Thailand cannabis licensing rules 2026 should therefore start with premises classification, not a licence form. ThaiCannaMed’s guide to converting a cannabis shop in Thailand compares the principal conversion routes and their operational consequences.
Change Two: The Address and Premises Must Align
The applicant must demonstrate lawful rights over the premises through ownership, possession or documented owner consent. Addresses should align across the application and supporting establishment authorisation.
Storage also matters. Legal commentary on the regulation describes requirements for dedicated storage appropriate to the expected volume, separation from other materials and conditions that preserve product quality. Herrera and Partners’ regulatory summary provides additional detail on premises, storage, prescriptions and document retention.
An owner should check whether stock is kept in another unit, office or warehouse not covered by the approval. A polished customer area cannot compensate for undocumented storage behind another door.
Change Three: Qualified People Must Be Genuinely Involved
The Thailand cannabis licensing rules 2026 impose requirements for both professional supervision appropriate to the establishment and trained on-site personnel. The professional requirement depends on the establishment type. DTAM’s guidance also states that every establishment must have at least one worker who has completed a recognised medical-cannabis training course present throughout operating hours. Owners should confirm the precise professional and trained-worker requirements applying to their chosen route rather than treating these roles as interchangeable alternatives.
This requirement must not be confused with prescribing authority. A person who satisfies an on-site staffing condition does not automatically have permission to diagnose or prescribe from that retail premises. Professional scope, workplace registration and the clinical setting still matter.
Where ThaiCannaMed provides its clinical pathway, a licensed Thai Traditional Medicine (TTM) doctor performs the assessment. The TTM doctor independently decides whether medical cannabis is appropriate and, if approved, determines the authorised quantity and a treatment period of no more than 30 days. Dispensary staff cannot diagnose, coach symptoms, promise approval or alter the PT33.
What Did Not Change in April: PT33 Was Already Required
The requirement for medical authorisation arose from the June 2025 medical-use controls, not solely from the April 2026 licensing amendment. Every purchase of controlled cannabis flower requires a valid Thai PT33 issued by an appropriately authorised Thai-licensed practitioner.
A foreign prescription, overseas cannabis card or customer declaration is not a substitute. The dispensary must verify the Thai document, supply no more than the authorised amount and record the sale. ThaiCannaMed’s PT33 prescription guide explains the patient-side process and the limits of the form.
The Thailand cannabis licensing rules 2026 therefore affect who may operate and under what conditions, while PT33 controls why and how flower may be supplied to an individual patient. Both must be satisfied.
PT28 and Traceability Remain Central
PT28 reporting creates part of the dispensary’s regulatory record; PT33 documents an individual patient’s medical authorisation. One cannot replace the other. ThaiCannaMed’s guide to PT28 and PT33 compliance explains how they support different sides of the same transaction.
The stock record should connect each product to a legitimate supplier, invoice, source, batch information and available quality evidence. Cannabis flower should be sourced through the authorised supply chain and meet the current GACP requirements applicable to medical cannabis. The sales record should connect that stock to the patient’s valid PT33, authorised quantity, date and receipt.
PT33 records must be retained at the dispensing premises for at least one year, while accounts and supporting inspection evidence must be retained for at least three years. Owners must also protect patient identity and medical information under Thailand’s data-protection requirements.
Advertising and Sales Channels Still Carry Risk
The move to medical use makes recreational-style advertising increasingly difficult to defend. Shops should review product claims, imagery, promotions, online content and staff language. They should not promise therapeutic results or present prescription approval as automatic.
Legal summaries of the Thailand cannabis licensing rules 2026 also identify restrictions involving online sales, vending machines, smoking on retail premises and sales in protected locations. Owners should verify each channel against the current Thai rules rather than assuming that a valid physical-store licence covers delivery, e-commerce or events.
Existing Licence Holders: Valid Does Not Mean Renewal-Ready
An existing flower licence may remain valid until its printed expiry date. That does not mean the same operation will qualify for renewal. The renewal process examines whether the business meets the newer premises, credential, staffing and record requirements.
Owners should conduct a gap analysis well before expiry covering:
- the licensed activity and exact expiry date;
- applicant, shareholder and director records;
- premises rights and address alignment;
- the eligible establishment route;
- professional and trained-personnel coverage;
- product classification and storage;
- supplier and batch traceability;
- PT28 reporting and retained evidence;
- PT33 verification and sales reconciliation; and
- privacy, advertising and inspection procedures.
The guide to the 2026 cannabis licence deadline provides a practical 90-day preparation schedule.
What the New Rules Mean Commercially
Compliance is not only a legal cost. It changes the economics of the shop. Professional staffing, eligible premises, broader product ranges, secure systems and lower-risk marketing can alter margins and customer acquisition.
At the same time, the Thailand cannabis licensing rules 2026 create a clearer dividing line between durable operators and shops relying on the assumptions of 2022. Businesses that can prove medical authorisation, source integrity and accurate reporting may gain trust as weaker operators leave the market.
The ThaiCannaMed Green Network supports suitable dispensaries with a structured clinical-access and PT33 workflow. It does not replace the owner’s licence, legal advice, eligible premises or reporting duties.
Build for the Rules That Exist Now
The Thailand cannabis licensing rules 2026 should not be reduced to one deadline, one form or one practitioner standing behind a counter. The current framework combines controlled-herb licensing, a medical-only sales pathway, patient-specific PT33 authorisation, dispensary reporting, traceable stock and separate controls for regulated extracts.
Owners who need support with the clinical and operating layer can contact ThaiCannaMed to discuss Green Network participation. The shops most likely to survive the Thailand cannabis licensing rules 2026 are those that understand every layer, document every transaction and prepare for renewal before the existing licence reaches its final day.
This article provides general information and is not independent legal, licensing or medical advice. Regulations, licensing procedures and official interpretations may change. Confirm current requirements with DTAM, the relevant licensing authority and qualified Thai legal advisers before making business decisions.